129 related articles for article (PubMed ID: 37190882)
1. Facial infiltrating lipomatosis with hemimegalencephaly and lymphatic malformations caused by nonhotspot phosphatidylinositol 3-kinase catalytic subunit alpha mutation.
Chen H; Sun B; Gao W; Jia H; Zhou L; Hua C; Lin X
Pediatr Dermatol; 2023; 40(6):1115-1119. PubMed ID: 37190882
[TBL] [Abstract][Full Text] [Related]
2. PIK3CA activating mutations in facial infiltrating lipomatosis.
Maclellan RA; Luks VL; Vivero MP; Mulliken JB; Zurakowski D; Padwa BL; Warman ML; Greene AK; Kurek KC
Plast Reconstr Surg; 2014 Jan; 133(1):12e-19e. PubMed ID: 24374682
[TBL] [Abstract][Full Text] [Related]
3. Delineation of the phenotypes and genotypes of facial infiltrating lipomatosis associated with PIK3CA mutations.
Chen H; Sun B; Gao W; Qiu Y; Hua C; Lin X
Orphanet J Rare Dis; 2023 Jul; 18(1):189. PubMed ID: 37452404
[TBL] [Abstract][Full Text] [Related]
4. Congenital infiltrating lipomatosis of the face with hemimegalencephaly.
Alkan O; Yildirim T; Seyhan T; Erbay G; Erol I
Neuropediatrics; 2009 Jun; 40(3):141-3. PubMed ID: 20020401
[TBL] [Abstract][Full Text] [Related]
5. Congenital infiltrating lipomatosis of the face with ipsilateral hemimegalencephaly, band heterotopia, and hypertrophy of brainstem and cerebellum.
Maruyama K; Okumura A; Negoro T; Watanabe K
Neuropediatrics; 2010 Jun; 41(3):147-50. PubMed ID: 20859836
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and surgical management of facial infiltrating lipomatosis: a single center experience.
Chen H; Sun B; Xia W; Qiu Y; Gao W; Hua C; Lin X
Head Face Med; 2024 Feb; 20(1):13. PubMed ID: 38378686
[TBL] [Abstract][Full Text] [Related]
7. Congenital Infiltrating Lipomatosis of Face Associated with Ipsilateral Hemimegalencephaly: An Uncommon Cause for Facial Asymmetry in a Child.
Aiyappan SK; Shanmugam V
Neurol India; 2023; 71(2):368-369. PubMed ID: 37148080
[No Abstract] [Full Text] [Related]
8. Somatic PIK3CA mutations are present in multiple tissues of facial infiltrating lipomatosis.
Couto JA; Konczyk DJ; Vivero MP; Kozakewich HPW; Upton J; Fu X; Padwa BL; Mulliken JB; Warman ML; Greene AK
Pediatr Res; 2017 Nov; 82(5):850-854. PubMed ID: 28665924
[TBL] [Abstract][Full Text] [Related]
9. Hemimegalencephaly associated with congenital infiltrating lipomatosis of the face: a case report.
Talamanca LF; Verdolotti T; Colafati GS; Bernardi B
Neuropediatrics; 2012 Dec; 43(6):349-52. PubMed ID: 22991064
[TBL] [Abstract][Full Text] [Related]
10. PIK3CA mutations in lipomatosis of nerve with or without nerve territory overgrowth.
Blackburn PR; Milosevic D; Marek T; Folpe AL; Howe BM; Spinner RJ; Carter JM
Mod Pathol; 2020 Mar; 33(3):420-430. PubMed ID: 31481664
[TBL] [Abstract][Full Text] [Related]
11. Congenital infiltrating lipomatosis of the face with ipsilateral hemimegalencephaly.
Aydíngöz U; Emir S; Karlí-Oğuz K; Köse G; Büyükpamukçu M
Pediatr Radiol; 2002 Feb; 32(2):106-9. PubMed ID: 11819077
[TBL] [Abstract][Full Text] [Related]
12. Congenital infiltrating lipomatosis of the face with lingual mucosal neuromas associated with a PIK3CA mutation.
Briand C; Galmiche-Rolland L; Vabres P; Couloigner V; Audebert S; Misery L; Abasq-Thomas C
Pediatr Dermatol; 2020 Nov; 37(6):1128-1130. PubMed ID: 32770747
[TBL] [Abstract][Full Text] [Related]
13. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.
Jansen LA; Mirzaa GM; Ishak GE; O'Roak BJ; Hiatt JB; Roden WH; Gunter SA; Christian SL; Collins S; Adams C; Rivière JB; St-Onge J; Ojemann JG; Shendure J; Hevner RF; Dobyns WB
Brain; 2015 Jun; 138(Pt 6):1613-28. PubMed ID: 25722288
[TBL] [Abstract][Full Text] [Related]
14. Hemimegalencephaly with Facial Congenital Infiltrating Lipomatosis in a Child.
Santana-Ramirez A; Farias-Serratos F; Sanchez-Corona J; Castañeda-Cisneros G; Farias-Serratos NM
Iran J Public Health; 2014 Dec; 43(12):1702-9. PubMed ID: 26171364
[TBL] [Abstract][Full Text] [Related]
15. [PIK3CA-related overgrowth syndrome (PROS)].
Venot Q; Canaud G
Nephrol Ther; 2017 Apr; 13 Suppl 1():S155-S156. PubMed ID: 28577738
[TBL] [Abstract][Full Text] [Related]
16. Somatic mosaicism for the p.His1047Arg mutation in PIK3CA in a girl with mesenteric lipomatosis.
Cohen AS; Townsend KN; Xiang QS; Attariwala R; Borchers C; Senger C; Picker W; Levi J; Yewchuk L; Tan J; Eydoux P; Lum A; Yong SL; McKinnon ML; Lear SA; Everett R; Jones SJ; Yip S; Gibson WT
Am J Med Genet A; 2014 Sep; 164A(9):2360-4. PubMed ID: 24903541
[TBL] [Abstract][Full Text] [Related]
17. Cerebrofacial vascular metameric syndrome is caused by somatic pathogenic variants in
Sheppard SE; Sanders VR; Srinivasan A; Finn LS; Adams D; Elton A; Amlie-Lefond C; Nelson Z; Dmyterko V; Jensen D; Zenner K; Perkins J; Bennett JT
Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34887309
[TBL] [Abstract][Full Text] [Related]
18. Mutation-Associated Phenotypic Heterogeneity in Novel and Canonical PIK3CA Helical and Kinase Domain Mutants.
Ghodsinia AA; Lego JMT; Garcia RL
Cells; 2020 Apr; 9(5):. PubMed ID: 32365913
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome.
Forde K; Resta N; Ranieri C; Rea D; Kubassova O; Hinton M; Andrews KA; Semple R; Irvine AD; Dvorakova V
Orphanet J Rare Dis; 2021 Feb; 16(1):109. PubMed ID: 33639990
[TBL] [Abstract][Full Text] [Related]
20. Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care.
Pirozzi F; Berkseth M; Shear R; Gonzalez L; Timms AE; Sulc J; Pao E; Oyama N; Forzano F; Conti V; Guerrini R; Doherty ES; Saitta SC; Lockwood CM; Pritchard CC; Dobyns WB; Novotny E; Wright JNN; Saneto RP; Friedman S; Hauptman J; Ojemann J; Kapur RP; Mirzaa GM
Brain; 2022 Apr; 145(3):925-938. PubMed ID: 35355055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
